このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV

2026年5月6日 更新者:Brendan Maughan-Brown、University of Cape Town

The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV in South Africa

Developed in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Coach Mpilo engages men living with HIV as coaches who provide support to their peers and help them address psychosocial barriers in accessing and staying in HIV care. The peers employed by Coach Mpilo provide individualized assistance to men who are struggling with medication adherence and clinic visits, focusing on specific barriers ranging from knowledge about the benefits of HIV treatment, stigma, mental health, and social isolation.

Through a randomised control trial, this project will (1) determine the impact of the Coach Mpilo intervention on retention in HIV care, viral suppression, HIV treatment adherence, mental health, HIV stigma, and economic status; (2) identify populations of men who may not benefit from the intervention and require alternative support; and (3) assess the intervention's cost-effectiveness.

調査の概要

状態

まだ募集していません

条件

介入・治療

詳細な説明

Study setting The study will be conducted in KwaZulu-Natal (KZN), the province in South Africa with the highest adult HIV prevalence: 16%-24% (model estimates), 22% (survey estimates). The study will be conducted in about 13 primary healthcare facilities based in the eThekwini District.

Aim 1: Determine the effects of Coach Mpilo on retention in care among men living with HIV In partnership with the Department of Health in KwaZulu-Natal Province, eThekwini Municipality, The Health Systems Trust (HST) and Matchboxology (a South African organisation that designs health and social programs) a randomised controlled trial (RCT) will be conducted with men living with HIV who have dropped out of HIV care (i.e., having missed a clinic appointment by >28 days).

Recruitment: Study staff will be trained by HST as Linkage Officers. As Linkage Officers, they will contact men who have missed clinic appointments via telephone, encourage return to care, and ask to meet privately at local venues. At the in-person meeting the Linkage Officers will invite eligible participants to enrol in the study.

Consenting process: Written informed consent will be obtained.

Data collection Baseline survey: Study staff will administer a baseline questionnaire to obtain information on, among other things, participants' demographic characteristics, socio-economic status, health behaviour, future outlook, internalized stigma and mental health.

Follow-up survey: Study staff will contact participants at six months and administer an in-person follow-up survey; many of the questions administered at baseline will be assessed again.

Clinic records: Participants' health outcome data will be obtained from electronic clinic data via TIER.Net (South Africa's national electronic HIV/TB monitoring system), to assess individual- and facility-level outcomes related to HIV. Where necessary physical clinic files will be reviewed for confirmation. In addition, participants' data on laboratory tests relevant for HIV care (including viral load tests) will be requested from the National Health Laboratory Services (NHLS).

Coach Log Book: To collect data on the engagement between coaches and their clients, the coaches will maintain a log book of the dates, duration and mode (e.g., in-person, telephone call, WhatsApp messages) of contact with clients.

Randomization: Following the baseline survey, participants will be randomized (1:1) to a control group that receives the SOC and an intervention group that receives SOC plus the Coach Mpilo intervention.

Analyses: Primary analysis will be intention-to-treat using a logistic regression model that includes clinic fixed effects and month of enrollment, and controls for baseline participant characteristics that are significantly different between study groups. Similar analyses will be conducted for each secondary outcome.

Sample size and power calculations: With a sample size of 786 participants and 50% retention in care at 12 months, the study has 80% power to detect a difference of 10 percentage points between study groups. As a result, the study will aim to recruit about 800 participants in the Aim 1 trial.

Aim 2: Identify the populations of men who are not reached by and do not respond to Coach Mpilo In the intervention group, intervention uptake and amount of engagement participants have with a coach will be measured. Primary quantitative analysis will assess the determinants of uptake within the intervention group to advance the limited evidence on sub-groups that are typically missed by peer-led interventions and therefore require different types of support. Qualitative interviews will also be conducted to better understand program uptake and engagement with a coach.

Participants: Aim 2 will be conducted with data collected from coaches and from Aim 1 trial participants.

Follow-up procedures and data collection: In-depth interviews (IDIs) with participants in the intervention arm who decline a coach. The study will conduct about 15 IDIs with 1) men who decline the support of a coach to understand reasons they did not engage with a coach; 2) about 15 IDIs with men who, after initial engagement, decline the support of a coach, this will be in order to understand reasons they chose to end engagements with a coach; 3) about 15 IDIs with participants who receive support from a coach to understand engagement with coaches and elicit insights on reasons why the intervention may have worked for some participants but not others. IDIs will be conducted at about 6 months, when engagement with a coach will have ended.

IDIs with all coaches (about N=7) involved in the study will be conducted to gain insights on their engagement with participants.

Analyses: Primary quantitative analysis: Among Aim 1 intervention group participants analysis will evaluate factors associated with declining the offer of a coach using logistic regression, controlling for potential covariates. Qualitative data analysis: Data analysis will be iterative, and include both deductive and inductive approaches to thematic analysis.

Aim 3: Assess the cost-effectiveness of the Coach Mpilo program To inform strategic policy decisions about the scale-up of Coach Mpilo, and how it compares in cost and cost-effectiveness against current standard of care treatment, as well as other HIV interventions, we will conduct an economic evaluation. Data collection includes: cost-related data and resource utilization data to construct cost estimates for both arms. These data will be combined with retention in care data from Aim 1 to determine average costs per client retained in care and incremental cost per additional person retained. As part of the analysis, a sub-analysis will be conducted to adjust the cost estimates to reflect implementation in a routine care setting, excluding research-related expenses such as start-up and study-specific costs. This will provide more realistic national-level scale-up cost estimates for Coach Mpilo. Epidemiological modeling based on effectiveness estimates from Aim 1, will use the Thembisa model to estimate several long-term health outcomes, including life years saved and HIV infections averted due to onward transmission. These long-term health outcomes will form the basis to estimate the cost-effectiveness analysis of Coach Mpilo. To compare Coach Mpilo to other HIV prevention and treatment options in South Africa with the broader aim of informing strategic policy decisions, study estimates will be incorporated into the South Africa HIV Investment Case, a prominent initiative that assesses the relative cost-effectiveness of different HIV interventions and aims to inform government of the optimal mix of interventions that also accounts for allocative efficiency.

Analyses

The analyses will be conducted in three phases:

Cost analysis: a multiprong approach will be used that incorporates top-down and bottom-up costing methodologies to construct a cost for both standard of care and Coach Mpilo arms.

Cost-effectiveness analysis: both intermediate and long-term cost effectiveness analysis (using an HIV transmission model) will be conducted, comparing Coach Mpilo to standard of care.

Integration into the HIV Investment Case: the cost-effectiveness of Coach Mpilo to other HIV prevention and treatment options in South Africa will be compared to inform strategic policy decisions for the South African government.

Aim 4: Assess the acceptability, feasibility and fidelity of the Coach Mpilo program To inform intervention refinements and policy decisions on the scale-up of Coach Mpilo and peer-led interventions more generally, quantitative and qualitative assessment of implementation outcomes will be conducted alongside effectiveness and cost-effectiveness of the intervention. Implementation outcomes will be viewed as important for evaluation of complex health interventions in research and practice, providing indications into the implementation process as preconditions for attaining intended intervention engagement and health outcomes.

Sekhon's 2017 Theoretical Framework for Acceptability (TFA) will be used to assess the feasibility and acceptability of the intervention, informing interpretation of effectiveness overall (Aim 1), for sub-groups (Aim 2), and cost-effectiveness (Aim 3) by describing how acceptable the intervention is and how feasible the intervention is to deliver, from different stakeholder perspectives, and by describing the fidelity of the intervention.

The following data will be collected: i) primary quantitative survey data at baseline and six month follow-up (through Aim 1 survey instruments); ii) primary qualitative data from intervention arm participants that decline a coach, participants who are supported by a coach at six-month follow up, and coaches immediately after the intervention stops being implemented (through Aim 2 IDI instruments); iii) routine administrative data during intervention preparation and implementation.

Quantitative: At baseline, participants' affective attitude and values alignment will be assessed to understand prospective acceptability. In the follow up survey with intervention arm participants, the Acceptability of Intervention Measure (AIM)19, and the Client Satisfaction Questionnaire (CSQ-8) will be asked.

Qualitative: Follow-up in-depth-interviews described in Aim 2 include topics which answer our implementation research questions, focusing on retrospective acceptability

Coach log: an existing routine administrative data collection tool has been adapted to focus on implementation choices, their determinants, and coach-participant relationship quality.

Coach-to-Coach WhatsApp Group: the implementing partner routinely establishes a WhatsApp group used by Coaches and the Squad Manager (i.e. not including any clients/participants). Data from this group will include challenges Coaches are facing and solutions suggested by other coaches.

Monthly and quarterly implementation reports and follow-up discussions: these reports will be developed by Matchboxology, providing both quantitative data on reach and their own observations on fidelity, reach, mechanisms of change and implementation strategies and determinants.

Analysis: Quantitative analysis. Among Aim 1 intervention group participants, descriptive analysis of data from the AIM and CSQ-8 scales and linear regression analysis will be conducted to assess what factors at baseline were associated with these scales. Qualitative data analysis. Ongoing saturation analyses will be conducted, based on iterative coding during data collection. Data analysis will be iterative, and include both deductive and inductive approaches to thematic analysis.

研究の種類

介入

入学 (推定)

800

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Male (cisgender or transgender);
  • aged ≥18 years;
  • previously receiving HIV care at the study clinic;
  • missed their most recent ART (antiretroviral therapy) clinic appointment by >28 days;
  • not planning to relocate to another region within the next 12 months;
  • able and willing to provide informed consent;
  • not currently taking ART

Exclusion Criteria:

  • not meeting inclusion criteria

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
介入なし:Control group
Standard of care (SOC) in our study is a once-off telephonic contact by a Study Linkage Officer to encourage the participant to return to HIV care. The Linkage Officer is trained to conduct the call in line with the South African National Guidelines on tracing and recall which involved making telephonic contact with an individual who has missed their HIV clinic appointment by 7 days. The National Guidelines for tracing also include a potential home visit if the telephone call is unsuccessful. Given our study sample is limited to men who have missed HIV clinic appointments by more than 28 days, all participants should already have received the standard tracing services provided by the health facility. In the study we conduct the tracing telephone call again to make sure all participants have received this service. No other intervention is provided.
実験的:Coach Mpilo group
The experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients.
The experimental group receives the standard of care for the control group (see control group description) and the Coach Mpilo intervention. Coach Mpilo employs 'coaches' (a term found to resonate with men and the concept of 'getting back in the game') to work 1-on-1 with men living with HIV ('players') and tailor support for each man to help him re-engage and stay in care. Coaches provide support for a period of up to six months, during which they engage with clients about once every week, with greater contact as needed based on the complexity of challenges faced. Coach Mpilo provides one-on-one, in-person support tailored to the individual needs of men living with HIV. As such, it may address the complex and varying psychosocial barriers to HIV care that traditional clinic-based interventions typically overlook. Coach Mpilo employs men living openly with HIV as coaches. This leverages the coaches' personal experiences to create a safe and supportive environment for clients.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Retention in HIV care
時間枠:12 months post study enrolment
Indicates whether a participant attended a follow-up clinic visit on or before 12 months after study enrolment and obtained adequate supply of antiretroviral therapy (ART) medication to have medication available at 12 months
12 months post study enrolment

二次結果の測定

結果測定
メジャーの説明
時間枠
ART clinic visit by 6 months
時間枠:6 months post study enrolment
Indicates whether an participant attends an antiretroviral therapy (ART) related clinic visit within 6 months of study enrolment
6 months post study enrolment
Retention in HIV care at 6 months
時間枠:6 months post study enrolment
Indicates whether a participant attended a follow-up clinic visit on or before 6 months after study enrolment and obtained adequate supply of antiretroviral therapy (ART) medication to have medication available at 6 month
6 months post study enrolment
Viral load test completed at 6 months
時間枠:6 months post study enrolment
Indicates whether a participant completed an HIV viral load test within 6 months of study enrolment
6 months post study enrolment
Viral suppression at 6 months
時間枠:3 to 9 months post study enrolment
Indicates whether a participant had a viral load test conducted between 3-9 months after study enrolment and the test result was an HIV viral load <50 copies/ml
3 to 9 months post study enrolment
Viral suppression at 12 months
時間枠:9 to 15 months post study enrolment
Indicates whether a participant had a viral load test conducted between 9-15 months after study enrolment and the test result was an HIV viral load <50 copies/ml
9 to 15 months post study enrolment
HIV status disclosure to sexual partners
時間枠:6 months post study enrolment
Indicates whether a participant disclosed their HIV status to all sexual partners reported in the 6 months prior to the 6 month follow-up survey
6 months post study enrolment
Mild to severe symptoms of mental depression
時間枠:6 months post study enrolment
Binary indicator of PHQ-9 score ≥5
6 months post study enrolment
Moderate to severe symptoms of mental depression
時間枠:6 months post study enrolment
Binary indicator of PHQ-9 score ≥10
6 months post study enrolment
Mild to severe symptoms of anxiety
時間枠:6 months post study enrolment
Binary indicator of GAD-7 score ≥5
6 months post study enrolment
Moderate to severe symptoms of anxiety
時間枠:6 months post study enrolment
Binary indicator of GAD-7 score ≥10
6 months post study enrolment
Employment
時間枠:6 months post study enrolment
Indicates whether a participant did any kind of work for pay or profit in the past 7 days
6 months post study enrolment
PHQ-9 scale
時間枠:6 months post study enrolment
The participant's score on the PHQ-9 scale, which assessed symptoms of depression. The Patient Health Questionnaire-9 (PHQ-9) score ranges from 0 to 27, with higher scores indicating greater depression severity.
6 months post study enrolment
GAD-7 scale
時間枠:6 months post study enrolment
The participant's score on the GAD-7 scale, which assesses symptoms of anxiety. The GAD-7 (Generalized Anxiety Disorder-7) scale ranges from 0 to 21, with higher scores indicating greater anxiety severity.
6 months post study enrolment
Internalised stigma
時間枠:6 months post study enrolment
Participant's score on the internalised stigma scale. The score ranges from 0 to 15, with higher scores representing greater internalised stigma.
6 months post study enrolment

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Harsha Thirumurthy, PhD、University of Pennsylvania
  • 主任研究者:Brendan G Maughan-Brown, PhD、University of Cape Town

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

便利なリンク

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年5月11日

一次修了 (推定)

2027年9月1日

研究の完了 (推定)

2027年9月1日

試験登録日

最初に提出

2026年4月26日

QC基準を満たした最初の提出物

2026年4月26日

最初の投稿 (実際)

2026年5月4日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月11日

QC基準を満たした最後の更新が送信されました

2026年5月6日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

Survey data and in-depth interview data; excluding personal identifying information

IPD 共有時間枠

Data will be made publicly available through DataFirst within 12 months from the data collection for the study

IPD 共有アクセス基準

Data will be available through DataFirst. Individuals who successfully register with DataFirst will have access. There are no specific exclusion criteria

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する